| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 273.45B | 284.07B | 254.51B | 300.59B | 257.23B |
| Gross Profit | 31.34B | 34.25B | 31.43B | 34.17B | 28.10B |
| EBITDA | 34.26B | 38.65B | 35.14B | 38.83B | 33.69B |
| Net Income | 54.77B | 31.86B | 27.79B | 27.23B | 17.89B |
Balance Sheet | |||||
| Total Assets | 639.79B | 626.06B | 679.14B | 573.69B | 562.19B |
| Cash, Cash Equivalents and Short-Term Investments | 63.03B | 63.39B | 61.02B | 64.00B | 52.96B |
| Total Debt | 114.89B | 118.10B | 119.34B | 107.77B | 104.77B |
| Total Liabilities | 255.26B | 246.78B | 267.44B | 219.25B | 214.43B |
| Stockholders Equity | 379.54B | 374.67B | 405.43B | 350.80B | 344.08B |
Cash Flow | |||||
| Free Cash Flow | -12.60B | 16.46B | 23.51B | 20.07B | -1.79B |
| Operating Cash Flow | 6.53B | 29.62B | 41.77B | 40.49B | 36.22B |
| Investing Cash Flow | 26.25B | 15.50B | -31.48B | -14.38B | -29.22B |
| Financing Cash Flow | -33.63B | -44.19B | -14.86B | -17.07B | -16.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥394.99B | 10.72 | 11.08% | 2.55% | 4.38% | 19.59% | |
68 Neutral | ¥925.56B | 10.15 | 9.97% | 3.54% | 10.41% | -13.82% | |
67 Neutral | ¥284.99B | 19.07 | ― | 2.94% | 4.66% | 72.15% | |
66 Neutral | ¥311.06B | 12.68 | 8.30% | 2.50% | 5.83% | -6.07% | |
65 Neutral | ¥500.69B | 8.48 | 13.93% | 2.81% | -3.74% | 81.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥998.10B | 310.63 | ― | 2.99% | -0.11% | -92.40% |